peptidylprolyl isomerase A pseudogene 55Genealiases: []
Q-omics provides the consensus-scored PPIAP55 profile across patient tissues and cancer cell-line models. PPIAP55 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, PPIAP55 is differentially expressed in 6, with the highest sampling consensus in COAD. Additionally, PPIAP55 RNA expression shows 9,814 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight ACC, and COAD as cancer lineages where PPIAP55 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for PPIAP55 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes PPIAP55 survival associations across molecular data types. PPIAP55 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible PPIAP55 RNA expression–survival associations across cancer types. High PPIAP55 expression shows unfavorable associations in ACC, KICH, LIHC and KIRC, but favorable associations in SKCM and THCA. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for PPIAP55 RNA expression.
This table summarizes PPIAP55 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 6. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for PPIAP55. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. PPIAP55 shows higher tumor expression in COAD, LIHC, LUAD, KIRC, CHOL and BLCA. The COAD box plot shows higher PPIAP55 RNA expression in tumor versus normal tissue (log2 FC = +0.427, t-test p < 0.001).
This table shows molecular features associated with PPIAP55 in patient tissues and cancer cell lines. In patient samples, PPIAP55 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
